Daily oral administration of WGP (400 μg) significantly reduced pulmonary eosinophil influx and production of Th2 cytokines (IL-4, IL-5, IL-13), however serum IgE levels were unaffected by WGP treatment in an OVA-induced asthma model. This evidence concerns the gene IL4 and asthma.